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Nitric oxide (NO), produced by NO
synthases (NOS), is a short-lived
intra- and transcellular messenger
that regulates many physiological
functions in vertebrates and
invertebrates (e.g., blood
pressure, muscle contraction,
innate immunity, cell division and
differentiation, response to
hypoxia, and memory formation
[1]). Given its numerous functions,
it might be expected that a lack of
NOS activity would be lethal for
the developing organism.
However, such an indispensable
role for NO in development has
not yet been demonstrated. A
genetic analysis of NO function in
vertebrates is complicated by the
presence of three NOS genes.
Mice with a homozygous ablation
of any single NOS gene are viable,
animals with two NOS genes
knocked out show drastically
reduced viability and triple
knockout animals have not yet
been generated [2–6].
To test whether NOS function is
essential for the developing
organism, we performed a genetic
study in Drosophila, which carries
a single NOS gene (dNOS) [7,8].
The dNOS locus encodes a family
of proteins including DNOS1, a full
length enzymatically active form,
which bears extensive similarity to
its mammalian sequelogs [9], and
whose activity is dependent on
the same cofactors as vertebrate
NOS proteins. dNOS1 is first
expressed in the embryo and later
in the larva, pupa and adult.
Our experimental approach was to
generate point mutations and test
them against a deficiency in the
dNOS locus. To generate the
deficiency, we mobilized the
l(2)k08405 P-element located
11 kb proximal to dNOS. This
produced a 20 kb deletion,
Df(2L)69F, which is homozygous
lethal and spans part of the dNOS
transcription unit along with five
flanking genes (Figure 1). Flies
heterozygous for this deletion
showed reduced levels of DNOS
protein and half the wild-type level
of NOS activity (Figure 1B,C). No
novel NOS-related peptides or
transcripts were revealed by
Western and Northern analyses of
flies bearing the deficiency
chromosome (data not shown).
We next generated 4855 mutant
lines, using ethyl methanesul-
fonate (EMS), and screened them
for lethality by complementation
with the deficiency chromosome.
32 lethal mutations, falling into five
complementation groups, were
identified (Supplemental Data).
Extracts from one of these
mutants, dNOSC, revealed
reduced levels of NOS enzymatic
activity (Figure 2), suggesting that
this strain carries a null mutation
in dNOS. We performed five
generations of outcrossing of the
mutant to wild-type flies, replacing
at least 95% of the original
mutated genome [10], and found
that in this new genetic
background the mutated gene still
conferred larval lethality to
homozygotes, indicating that the
effect is not due to a secondary
mutation. Sequence analysis of
genomic DNA from the dNOSC
strain identified a single G to A
transition corresponding to
position 1942 of the dNOS1
mRNA, creating a glycine (Gly) to
glutamic acid (Glu) substitution at
position 585 of DNOS1 (Figure
2B). We expressed the mutated
DNOS1 protein in cell culture and
found that its enzymatic activity
was abolished even though the
protein was expressed at the
same level as wild-type DNOS1 in
this assay (Figure 2C,D). Flies
homozygous for the
DNOSGly585Glu mutation die
during late embryonic and larval
stages, demonstrating that DNOS
Figure 1. The dNOS gene is disrupted in the Df(2L)69F chromosome.
(A) Genes within 50 kb of the Drosophila genome surrounding dNOS and mitochondrial
porin genes. Arrows depict transcription units. The dNOS transcription unit is indicated
by the top arrow and vertical bars indicate approximate location of dNOS exons. CG6508
and CG17134 are cathepsinD-like genes nested within intron 8 of dNOS. CG17137,
CG17139 and CG17140 refer to three genes with strong homology to mitochondrial porin,
CG6647. The triangle shows the location of the l(2)k8405 P-element insertion, which was
used to generate the deficiency Df(2L)69F shown in the bottom part of the figure.
‘R’ = EcoRI sites. (B) Western blot: head protein extracts (50µg/lane) prepared from
Df(2L)69F/CyO (69F) show a decreased level of DNOS1 protein compared to the parental
line l(2)k8405/CyO (P84). The Western blot was probed with mAb 6/157 raised against the
carboxyl-terminus of DNOS. (C) NOS activity in head extracts (20 µg/lane) prepared from
deficiency Df(2L)69F/CyO or parental l(2)k8405/CyO heterozygotes.
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is required for normal Drosophila
development. The mutated
glycine residue is conserved
across all characterized NOS
proteins (Figure 2B) and appears
to be located at an invariant
position in the three-dimensional
structure (based on the crystal
structure of mammalian NOS).
Although Gly585 does not map to
any previously identified
functional domain of NOS, it
appears to play a structural role.
This residue cannot be replaced
without significant perturbation of
the local protein structure given
that the glycine φ,ψ -angles fall in
disallowed regions of the
Ramachandran plot.
The 16 other lethal mutations in
the dNOS complementation group
that we have generated will help
to define other critical functional
domains of NOS. Our results in
Drosophila provide the first
evidence that NOS function is
essential for development. In
mammals, the effect of a NOS
deficiency may be masked by the
compensatory action of other
NOS isoforms, obscuring the true
importance of NO signaling in
normal development and
physiology.
Supplemental data
Supplemental data are available
at http://www.current-
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Figure 2. dNOSC is a null allele of the dNOS gene.
(A) NOS activity measured in head extracts prepared from wild-type flies (WT; w1118 (CJiso1)) or dNOSC/CyO (C/CyO) is decreased
in the heterozygote. (B) Alignment of the region surrounding the dNOSC mutation with corresponding regions from a selected group
of NOS proteins shows that dNOSC affects a conserved glycine. (C) Western blot analysis of cell culture extracts (293 human embry-
onic kidney cells; 293 HEK) indicates that wild-type (dNOS) and mutant (dNOSC) DNOS proteins are expressed at comparable levels.
(D) Enzymatic assay: NOS activity, measured in the same extracts as in (C), is absent from the mutant protein as compared with the
control. dNOS + L-NMMA, which contains 1 mM NOS inhibitor L-NMMA, indicates the baseline activity in this assay.
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